tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate

Catalog No. :
ACYMXT235
CAS No. :
857898-70-5
Molecular Formula :
C18H26N2O2
Molecular Weight :
302.42

IUPAC Name:tert-butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate

tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$195.00Login to see priceInquiryInquiry
250mg95%$303.00Login to see priceInquiryInquiry
1g95%$702.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate
IUPAC Nametert-butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate
MDL No.MFCD09959723
Molecular FormulaC18H26N2O2
Molecular Weight302.42
SMILESO=C(N1CC2=C(C=CC=C2)C3(CCNCC3)C1)OC(C)(C)C
InChI KeyPYRPHEQXDLNURT-UHFFFAOYSA-N
Synonymtert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate | 857898-70-5 | tert-butyl spiro[1,3-dihydroisoquinoline-4,4'-piperidine]-2-carboxylate | MFCD09959723 | tert-butyl 2,3-dihydro-1H-spiro[isoquinoline-4,4'-piperidine]-2-carboxylate | SCHEMBL652952 |
CAS No.857898-70-5
PubChem CID49760902

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACYMXT235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYMXT235 route product structure diagram
    ACYMXT235857898-70-5
Inquiry

2. ACYMXT235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYMXT235 route product structure diagram
    ACYMXT235857898-70-5
Inquiry

Comments (0)